STAYBLE THERAPEUTICS

Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain triggered by degenerative changes in the disc. Stayble’s treatment has the potential to offer a solution that may alleviate or abolish the pain without the need for surgery Behind Stayble Therapeutics stands an experienced, multidisciplinary team including a world-renowned back-pain researcher, experienced bio-entrepreneurs and former big pharma senior management. Their vision is that this treatment concept will reach out to millions of patients who are disabled by chronic back pain. We believe this drug has the potential to drastically reduce the suffering from a widespread, incapacitating condition.

#SimilarOrganizations #People #Financial #Website #More

STAYBLE THERAPEUTICS

Social Links:

Twitter

Industry:

Biotechnology Health Care Medical Device Therapeutics

Founded:

2012-01-01

Address:

Göteborg, Vastra Gotaland, Sweden

Country:

Sweden

Website Url:

http://www.staybletherapeutics.com

Total Employee:

Status:

Active

Contact:

+46 730 808 397

Email Addresses:

[email protected]

Total Funding:

1.66 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt WordPress Content Delivery Network Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box Yoast WordPress SEO Plugin

Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

Current Advisors List

erik-kinnman_image

Erik Kinnman Board Member @ Stayble Therapeutics
Board_member
2020-01-01

kjell-olmarker_image

Kjell Olmarker Board Member and Inventor @ Stayble Therapeutics
Board_member

Current Employees Featured

mattias-münnich_image

Mattias Münnich
Mattias Münnich V.P. Business Development @ Stayble Therapeutics
V.P. Business Development
2017-01-01

andreas-gerward_image

Andreas Gerward
Andreas Gerward CEO @ Stayble Therapeutics
CEO
2014-01-01

anders-lehmann_image

Anders Lehmann
Anders Lehmann Vice President Development @ Stayble Therapeutics
Vice President Development
2015-01-01

Stock Details

Company's stock symbol is STO:STABL

Investors List

chalmers-ventures_image

Official Site Inspections

http://www.staybletherapeutics.com Semrush global rank: 5.42 M Semrush visits lastest month: 1.56 K

Host Informations
Whois Informations

Loading ...